Page 109 – Clinical Laboratory int.

Bio-Rad’s CFX Opus Deepwell Dx Real-Time PCR System Advances Large Reaction Volume IVD Assay Development and Diagnostic Testing

, 2 February 2023/in E-News /by panglobal

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced the launch of the CFX Opus Deepwell Dx Real-Time PCR System, a real-time PCR system listed with the U.S. Food and Drug Administration (FDA) for in vitro diagnostic (IVD) testing, and developed in accordance with […]

Wi-Fi enabled tube reader

, 2 February 2023/in Product News /by panglobal

The DataPaq™ Handheld 2 tube reader from Ziath can be held and operated in one hand, leaving the other free for tube handling. Designed for easy portability, the Handheld 2 is a dedicated standalone device for rapidly reading single 2D bar-coded tubes. Its highly intuitive interface, and easy-to-read display, simplify and speed operation.

TRIMERO Diagnostics offers assays for testing Serum Amyloid A (SAA) on Beckman Coulter’s IMMAGE® Immunochemical Systems and Clinical Chemistry Analyzers.

, 30 January 2023/in Product News /by panglobal

Main features of the assays are: particle-enhanced rate-nephelometric method (kinetic-PENIA) for IMMAGE® 800 particle-enhanced turbidimetric method for clinical chemistry analyzers values traced to the Serum Amyloid A (SAA) 1st International Standard (NIBSC code: 92/680) of the WHO (World Health Organization).

DiaSys Procalcitonin FS is a fluid-stable, particle enhanced immunoturbidimetric assay, applicable on various clinical chemistry analyzers.

, 27 January 2023/in Product News /by panglobal

The assay shows good precision at clinical cut-off level, a wide measuring range and high prozone security. Furthermore, Procalcitonin FS has excellent onboard and calibration stability and a high tolerance to endogenous interferents and common therapeutics used in sepsis management.

Tetra Pharm Technologies secures €9 million in Series A Round to expand R&D Operations

, 26 January 2023/in E-News /by panglobal

The Scandinavian Biotech company, Tetra Pharm Technologies has secured €9M in a series A round led by a group of Danish investors. The company, with operations in Copenhagen, Denmark focuses on therapeutics targeting the endocannabinoid system to treat neuropathic pain and mental health disorders.

Watchmaker Genomics is proud to announce that its Quality Management System has achieved ISO 13485:2016 certification.

, 26 January 2023/in E-News /by panglobal

ISO 13485 is an internationally recognized standard that sets out the requirements for a quality management system for the medical device industry. Our certificate has been awarded for the design, development, manufacture, contract manufacture, distribution, and support of high-performing reagents for genomic applications in medical research.